The Biotechnology Industry Organization’s annual BIO-CEO conference on Feb. 23-24 is featuring an RNAi discussion panel this year featuring six top industry exectives.
Sirna Therapeutics’ president and CEO Howard Robin is set to present, as is Alnylam Pharmaceuticals’ president and CEO John Maraganore.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
